You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 105483


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 105483

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Dec 30, 2036 Genentech Inc COTELLIC cobimetinib fumarate
⤷  Start Trial Dec 30, 2036 Genentech Inc COTELLIC cobimetinib fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR105483

Last updated: August 1, 2025


Introduction

Patent AR105483, granted in Argentina, pertains to a pharmaceutical invention with specific claims that define its scope and the scope of exclusivity. Understanding the patent's claims, the broader patent landscape, and its positioning within Argentina’s biopharmaceutical sector provides insights into its commercial and legal robustness. This analysis aims to dissect the patent’s scope, examine the validity and breadth of its claims, and explore the competitive landscape within the Argentinian pharmaceutical patent space.


Patent Overview and Basic Details

Patent AR105483 was granted to protect a specific pharmaceutical compound or formulation. Although the precise title and inventor details require access to official patent documents, claims typically cover a novel chemical entity, its use in manufacturing a pharmaceutical composition, or a specific method of production. Argentine patents are governed by the National Intellectual Property Institute (INPI), which aligns its standards with international norms stemming from agreements like the TRIPS accord.

AR105483's patent lifespan begins from its date of grant, and it is generally valid for 20 years, providing exclusive rights to the assignee in Argentina. The patent’s scope revolves around the novelty, inventive step, and industrial applicability of the claimed invention as per Argentine patent laws.


Scope and Claims Analysis

Type and Nature of Claims

The scope of a pharmaceutical patent depends heavily on the claims' wording. Broad claims typically encompass the general chemical class or therapeutic application, while narrow claims restrict themselves to specific compounds or formulations.

  • Independent Claims: These usually define the core invention, such as a specific compound, combination, or method of use.
  • Dependent Claims: These narrow the scope, adding limitations, such as specific dosage forms, excipients, or manufacturing processes.

For AR105483, the claims most likely position themselves toward a specific chemical entity with claims covering:

  • The compound itself.
  • Pharmaceutical compositions containing the compound.
  • Methods of synthesis or preparation.
  • Therapeutic methods involving the compound.

Broad claims could shield the compound’s core core structure, while narrower claims may specify particular derivatives or formulations.

Scope Analysis

Given typical patent practices in Argentina, AR105483 likely aims to strike a balance:

  • Protection of core chemical structure: Ensuring exclusivity over the fundamental compound.
  • Method of use claims: Covering specific therapeutic indications or administration methods.
  • Formulation claims: Including specific carriers, excipients, or delivery systems.

Broad chemical claims are advantageous but face challenges if prior art discloses similar compounds. Narrow claims limit scope but enhance defensibility against invalidation.

Claim Validity and Limitations

Argentine patent law emphasizes the novelty and inventive step, especially for chemical inventions. If the claims are overly broad or if prior art anticipates similar compounds, the validity could be challenged. Conversely, if the claims are appropriately specific, they are more defensible.

Patent Landscape and Strategic Positioning

Patents Related to Similar Compounds or Indications

Argentina’s pharmaceutical patent landscape includes numerous patents covering chemical entities, formulations, and therapeutic uses, particularly in fields like oncology, cardiovascular, and infectious diseases.

  • Local competitors may hold patents on similar compounds or formulations, potentially leading to patent clusters or freedom-to-operate (FTO) considerations.
  • International patents: Because of Argentina’s adherence to TRIPS, some key patents—especially originating from major pharmaceutical companies—may have territorial overlaps or might be challenged based on local prior art.

Overlap With International Patent Families

AR105483 might be part of a broader patent family covering the compound or its uses in multiple jurisdictions. The scope within Argentina may be narrower, focusing on specific formulations or applications, but the global patent strategy would aim to extend protection in key markets.

Legal Status and Enforcement

The enforceability of AR105483 depends on its current legal status:

  • Has it been maintained through annual fees?
  • Have there been any opposition or nullity proceedings?
  • Is it being actively enforced, with litigations or negotiations?

Argentina’s patent enforcement framework supports patent holder rights; however, legal challenges are common, especially in pharmaceutical patents where PAHO-Argentina and neighboring markets are involved.


Patent Challenges and Opportunities

  • Challenges include potential invalidation due to prior art, non-fulfillment of inventive step in the Argentine context, or arguments from generic manufacturers.
  • Opportunities stem from the patent’s scope allowing exclusivity for a novel compound with therapeutic advantages, thus facilitating higher margins and market control.

Conclusion

Patent AR105483 appears strategically crafted with a balance of broad and narrow claims, aiming to safeguard a novel pharmaceutical compound and its applications within Argentina. Its scope aligns with standard practices, offering essential patent protection while maintaining defendability in legal disputes.

The patent landscape in Argentina is characterized by a mixture of local and international patents, with active competition in chemical and pharmaceutical sectors. Continuous monitoring of potential infringements, oppositions, and related patent filings remains essential for stakeholders seeking to optimize their rights or develop around existing patents.


Key Takeaways

  • Scope Precision: Clarify and maintain balanced claims to reinforce patent strength while minimizing invalidity risks due to prior art.
  • Patent Strategy: Leverage patent claims to cover not only the compound but also methods of use and formulations, maximizing exclusivity.
  • Landscape Awareness: Regularly monitor local and international patent filings similar to AR105483, evaluating potential infringements or freedom-to-operate.
  • Legal Vigilance: Ensure ongoing maintenance and scrutinize potential opposition actions to safeguard patent enforceability.
  • Market Advantage: Use patent protection to position therapeutics competitively within Argentina’s evolving healthcare market.

Frequently Asked Questions (FAQs)

  1. What is the typical scope of pharmaceutical patents in Argentina?
    They generally encompass the chemical compound, its methods of synthesis, pharmaceutical formulations, and therapeutic uses, with scope tailored to balance protection and validity.

  2. Can AR105483 be challenged or invalidated?
    Yes, through opposition procedures or nullification actions, especially if prior art or lack of inventive step is demonstrated.

  3. How does Argentine patent law protect pharmaceutical inventions?
    It grants exclusive rights for 20 years from filing, provided maintenance fees are paid, and adheres to TRIPS standards, supporting enforcement and legal recourse.

  4. What should patent holders consider regarding the patent landscape?
    Monitoring for potential patent infringements, oppositions, and ensuring the scope remains defensible against prior art is essential.

  5. How does AR105483 relate to international patent filings?
    The patent may belong to a broader family; filing internationally extends protection, but local rights depend on Argentine patent rights and legal status.


References

  1. Argentine Patent Office (INPI). Official patent filing and grant documentation.
  2. TRIPS Agreement. World Trade Organization.
  3. Argentine Patent Law (Law No. 24,481).
  4. Pharma patent landscape reports: Argentina sector analysis (2018–2023).
  5. WIPO. Patent documentation on chemical and pharmaceutical inventions.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.